These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34689485)

  • 1. The Relationship between Polycystic Ovary Syndrome and Serum Periostin Level.
    Gonulalan G; Guney I; Sackan F; Acar S
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1291-1295. PubMed ID: 34689485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome.
    Bicer M; Alan M; Alarslan P; Guler A; Kocabas GU; Imamoglu C; Aksit M; Bozkaya G; Isil AM; Baloglu A; Aslanipoiur B; Calan M
    J Endocrinol Invest; 2019 Mar; 42(3):303-312. PubMed ID: 29956214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
    Gursoy Calan O; Calan M; Yesil Senses P; Unal Kocabas G; Ozden E; Sari KR; Kocar M; Imamoglu C; Senses YM; Bozkaya G; Bilgir O
    Clin Endocrinol (Oxf); 2016 Dec; 85(6):910-917. PubMed ID: 27434652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serum protein α2-Heremans-Schmid glycoprotein/fetuin-a concentration and carotid intima-media thickness in women with polycystic ovary syndrome.
    Abali R; Celik C; Tasdemir N; Guzel S; Alpsoy S; Yuksel A; Celik E
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):45-9. PubMed ID: 23433744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome.
    Karbek B; Ozbek M; Karakose M; Topaloglu O; Bozkurt NC; Cakır E; Aslan MS; Delibasi T
    J Ovarian Res; 2014 Mar; 7():31. PubMed ID: 24628831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of increased levels of omentin-1 and carotid intima-media thickness with early signs of cardiovascular risk in patients with polycystic ovary syndrome: A prospective case control study.
    Alanya Tosun Ş; Gurbuz T; Cebi A; Tosun A; Gokmen O; Usta M
    J Obstet Gynaecol Res; 2022 Jan; 48(1):169-177. PubMed ID: 34676949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk in the siblings of women with polycystic ovary syndrome.
    Karthik S; Vipin VP; Kapoor A; Tripathi A; Shukla M; Dabadghao P
    Hum Reprod; 2019 Aug; 34(8):1559-1566. PubMed ID: 31299073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
    Bicer M; Guler A; Unal Kocabas G; Imamoglu C; Baloglu A; Bilgir O; Yuksel A; Bozkaya G; Calan M
    Endocr Res; 2017 May; 42(2):145-153. PubMed ID: 27911121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism.
    Cakir E; Doğan M; Topaloglu O; Ozbek M; Cakal E; Vural MG; Yeter E; Delibasi T
    Atherosclerosis; 2013 Jan; 226(1):291-5. PubMed ID: 23206979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles.
    Jabbour R; Ott J; Eppel W; Frigo P
    PLoS One; 2020; 15(4):e0232299. PubMed ID: 32330202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome.
    Calan M; Guler A; Unal Kocabas G; Alarslan P; Bicer M; Imamoglu C; Yuksel A; Bozkaya G; Bilgir O
    Minerva Endocrinol; 2018 Sep; 43(3):236-245. PubMed ID: 28294594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cardiovascular risk vary according to the criteria for a diagnosis of polycystic ovary syndrome?
    Ramoglu S; Yoldemir T; Atasayan K; Yavuz DG
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1848-1854. PubMed ID: 28892255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic Ovary Syndrome is Associated with Elevated Periostin Levels.
    Chen X; Huo L; Ren L; Li Y; Sun Y; Li Y; Zhang P; Chen S; Song GY
    Exp Clin Endocrinol Diabetes; 2019 Oct; 127(9):571-577. PubMed ID: 30372763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of carotid intima-media thickness and visceral obesity as an atherosclerosis predictor in newly-diagnosed polycystic ovary syndrome.
    Buyukkaya R; Besir FH; Yazgan S; Karatas A; Kose SA; Aydin Y; Erdogmus B
    Clin Ter; 2014; 165(1):e6-11. PubMed ID: 24589963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carotid intima-media thickness in mainly non-obese women with polycystic ovary syndrome and age-matched controls.
    Kim JJ; Choi YM; Kang JH; Hwang KR; Chae SJ; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Obstet Gynecol Sci; 2013 Jul; 56(4):249-55. PubMed ID: 24328010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.
    Meyer ML; Malek AM; Wild RA; Korytkowski MT; Talbott EO
    Hum Reprod Update; 2012; 18(2):112-26. PubMed ID: 22108382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen excess is associated with the increased carotid intima-media thickness observed in young women with polycystic ovary syndrome.
    Luque-Ramírez M; Mendieta-Azcona C; Alvarez-Blasco F; Escobar-Morreale HF
    Hum Reprod; 2007 Dec; 22(12):3197-203. PubMed ID: 17933750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.